BioSpace News Archive

Job Trends

New Biopharma Job Expansions Help Ring in the New Year

While many industries are struggling, biopharma is booming. Here’s an overview of last month’s company expansion announcements, who’s growing their footprint and adding more jobs.

January 27, 2021
·
3 min read
·
Kate Goodwin
Drug Development

UK Offers Genomics Expertise to Help Nations ID New SARS-CoV-2 Variants

On Tuesday, the U.K. offered its genomics expertise to identify emerging variants of the SARS-CoV-2 virus to countries that lack the resources to make such identifications.

January 27, 2021
·
4 min read
·
Gail Dutton
Drug Development

News Brief: J&J Could Supply U.S. with 100 Million COVID-19 Vaccine Doses and More

J&J indicated it will soon release Phase III data and could file for Emergency Use Authorization with the U.S. Food and Drug Administration by the end of the month.

January 27, 2021
·
3 min read
·
Alex Keown
BioSpace Global Roundup: Piloxa Evaluates Digital Adherence Solution in CD Patients

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

January 27, 2021
·
4 min read
·
Alex Keown
Bio NC

BioSpace Launches 2021 Hotbed Maps to Highlight Thriving Life Sciences Clusters

See the companies featured in our 2021 maps, explore the territories that are thriving in the life sciences industry, research leading employers and search for relevant jobs on BioSpace.

January 27, 2021
·
4 min read
·
Ellen Bombela
Pharm Country

Pfizer’s RA Hopeful Fails to Meet Co-Primary Endpoint in Safety Study

Pfizer announced in a statement on Wednesday that the prespecified non-inferiority criteria for a post-marketing safety study of rheumatoid arthritis (RA) drug XELJANZ® (tofacitinib) were not met.

January 27, 2021
·
3 min read
·
Brandon May
Genetown

Cancer Startup Nuvalent Launches With $50 Million Series A Financing

The Series A financing will help fuel Nuvalent’s research and development efforts for a portfolio of innovative small molecule kinase inhibitors for programs in non-small cell lung cancer.

January 27, 2021
·
3 min read
·
Brandon May
Genetown

COVID-19 Vaccines Only Tip of the Iceberg for These Leaders

Much of the attention on Pfizer, BioNTech, Moderna, Johnson & Johnson and AstraZeneca for the last few months has been on their COVID-19 vaccine efforts.

January 27, 2021
·
5 min read
·
Mark Terry
Drug Development

More Positive Data Sets Up Agios’ Mitapivat for Regulatory Filings This Year

Agios reported its second positive Phase III readout for small molecule mitapivat to treat pyruvate kinase deficiency, this time meeting its primary endpoint of reduced blood transmission burden.

January 27, 2021
·
2 min read
·
Mark Zipkin
Business

IBRI Researchers Find Opportunity to Repurpose Drugs for Type 1 Diabetes

A team led by Dr. Decio Eizirik, M.D., Ph.D., Scientific Director for Indiana Biosciences Research Institute Diabetes Center, has taken a step back from the traditional immune system study approach and found potential for treatment and, theoretically, even a cure.

January 27, 2021
·
4 min read
·
Kate Goodwin